Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity.
about
Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathiesMetabolic abnormalities and cardiovascular risk factors in children with myositisComplete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis.The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126.A Report of Three Cases With Acquired Generalized Lipodystrophy With Distinct Autoimmune Conditions Treated With Metreleptin.Lymphoma in acquired generalized lipodystrophy.Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis.Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?Cardiovascular risk in pediatric-onset rheumatological diseases.Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents.Novel forms of lipodystrophy: why should we care?The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomesMyositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index.Dermatomyositis Leading to Necrotizing Vasculitis: A Perfect Response to Applied Therapy.Radiographically occult femoral and pelvic fractures are not mutually exclusive: a review of fractures detected by MRI following low-energy trauma.Clinical analysis of 50 children with juvenile dermatomyositis.The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review.Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies.Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.The Clinical Features of Myositis-Associated Autoantibodies: a Review.Serological subsets of juvenile idiopathic inflammatory myopathies--an update.CANDLE Syndrome As a Paradigm of Proteasome-Related Autoinflammation.Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.Focal lipodystrophy without metabolic disorders in adult dermatomyositis.Trajectories of cardiorespiratory fitness in patients with juvenile dermatomyositis.Case of lipoatrophic diabetes induced by juvenile dermatomyositis.Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis.Lower extremity lipedema, upper extremity lipodystrophy and severe calcinosis complicating juvenile dermatomyositis
P2860
Q26863125-5D6FF5E8-2F25-4C7B-BCAF-DC87BFA4AAE8Q33602858-1301DEDA-7A87-428F-916B-451E0A1D783EQ34626240-6F3A45DA-A169-4821-9BE7-5667E0368A83Q35009335-D5C0F567-5443-4475-B715-1D657AB0E6C5Q35349884-087DF638-26DB-42D6-96F8-8F866C7AB462Q36086954-DF0D573A-E892-4F65-936C-360DBB2FDC60Q36312962-99848D85-62D0-481E-811D-C72930B72384Q36433604-35EC5ED6-B3E3-40D4-922A-58FBA1071466Q36584738-54F1BBEF-03EB-40BA-9342-4F65E0B11439Q36619819-393B0A25-4296-4A49-912A-567285F5D2B2Q36903076-94FFBB91-FE7C-4C2D-80A2-67FF3137C57FQ36903089-F823CDE9-2F61-4381-9943-A8B66A6C7931Q36994516-6E76DBBF-6BC3-4ACB-A9D3-6104BFAFE074Q37022579-B65A4B8F-740A-4A79-85B9-A6DA93E0FEB8Q37022721-6C01ECB5-F5C2-497C-96ED-D3AF211C9B53Q37368405-18578638-A888-472A-891A-FAC37A6382F6Q37475947-64B7BD5E-FE01-4F9D-BB84-F2101DED2869Q37608074-2D076ABD-3CBC-48B7-89B9-579857F9B968Q37954564-875EEA55-745A-419D-B17C-244249FA9C16Q38004835-D89D65BA-5404-4F75-8CAF-4B3AEFDFF98CQ38139286-B6914DF5-78D4-4288-A76E-936B55E3559FQ38281749-79350C2E-589D-4567-9912-5AA2AAB203BEQ38534871-1ED623FA-C4AF-4C10-BEC5-787ECF3AABDAQ38597575-099333C3-E04C-444E-B1E8-0BB169F1F9D9Q38603422-99C843BD-682D-4BB3-8E8A-7535A57D9FA4Q38664251-18BC86A6-4FE7-4D63-939D-2C4D36605E53Q40067147-50CA5F7D-51A7-47EA-8CD9-FF625DA3962EQ42632915-CF1631F1-38A5-4009-9AD2-BDDACEA35357Q43413071-579FE24B-367E-404A-9EB4-E998579AEB92Q47800428-AEE28D94-D707-4884-B6C6-5479380F2BA6Q48087930-64E2CD88-83BB-4ABD-8735-3A258A10BCECQ52722134-5344D668-49A4-4933-B549-0958792EAEF4Q57183183-C67A3B7D-76B9-441F-A5AF-910C65E9ABEE
P2860
Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predictors of acquired lipodys ...... is and a gradient of severity.
@en
Predictors of acquired lipodys ...... is and a gradient of severity.
@nl
type
label
Predictors of acquired lipodys ...... is and a gradient of severity.
@en
Predictors of acquired lipodys ...... is and a gradient of severity.
@nl
prefLabel
Predictors of acquired lipodys ...... is and a gradient of severity.
@en
Predictors of acquired lipodys ...... is and a gradient of severity.
@nl
P2093
P2860
P1433
P1476
Predictors of acquired lipodys ...... is and a gradient of severity.
@en
P2093
Ahalya Premkumar
April Bingham
Childhood Myositis Heterogeneity Study Group
Danielle Mercatante Carrick
David Kleiner
Elaine Cochran
Frederick W Miller
Gulnara Mamyrova
Ira N Targoff
P2860
P356
10.1097/MD.0B013E31816BC604
P407
P577
2008-03-01T00:00:00Z